Dillard's (DDS) 63.88 $DDS Dillard's Has Returned 26.7%

New Post Public Reply Private Reply Replies (0) Message Board

Jul 13, 2016 at 10:17 PM

Dillard's (DDS) 63.88 $DDS

Dillard's Has Returned 26.7% Since SmarTrend Recommendation (DDS)
Comtex SmarTrend(R) - Wed Jul 06, 1:23PM CDT
SmarTrend identified a Downtrend for Dillard's (NYSE

DS) on April 5th, 2016 at $80.58. In approximately 3 months, Dillard's has returned 26.69% as of today's recent price of $59.07.
DDS: 63.88 (-1.19)

After Yesterday's Rally of 3.00% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Wed Jun 15, 2:22PM CDT
Dillard's (NYSE

DS) traded in a range yesterday that spanned from a low of $56.87 to a high of $59.29. Yesterday, the shares gained 3.0%, which took the trading range above the 3-day high of $58.60 on volume of 387,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
DDS: 63.88 (-1.19)

Dillard's Set to Possibly Pullback After Yesterday's Rally of 3.00%
Comtex SmarTrend(R) - Wed Jun 15, 2:21PM CDT
Dillard's (NYSE

DS) traded in a range yesterday that spanned from a low of $56.87 to a high of $59.29. Yesterday, the shares gained 3.0%, which took the trading range above the 3-day high of $58.60 on volume of 387,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
DDS: 63.88 (-1.19)

Dillard's Shares Down 25.5% Since SmarTrend's Sell Call (DDS)
Comtex SmarTrend(R) - Fri May 27, 1:33PM CDT
SmarTrend identified a Downtrend for Dillard's (NYSE

DS) on April 5th, 2016 at $80.58. In approximately 2 months, Dillard's has returned 25.45% as of today's recent price of $60.07.
DDS: 63.88 (-1.19)

4 Retail Stocks to Avoid Now Post Dismal Earnings
Zacks Equity Research - Zacks Investment Research - Thu May 26, 9:33AM CDT
With the first-quarter earnings season now effectively behind us, the retail sector is the only one still hogging the limelight, as a few stocks are lined up to report their financials.
DDS: 63.88 (-1.19), KSS: 38.50 (-1.26), AMZN: 742.63 (-5.58), CTRN: 17.34 (+0.09), JWN: 41.10 (-0.52)

What Falling Estimates & Price Mean for Dillard's (DDS)
Zacks Equity Research - Zacks Investment Research - Wed May 25, 7:55AM CDT
Dillard's has witnessed a significant price decline in the past four weeks and negative estimate revisions, making it time for investors to sell it off.
DDS: 63.88 (-1.19), BBY: 31.40 (-0.13)

Dillard's, Inc. Announces $0.07 Cash Dividend
BusinessWire - Mon May 23, 3:15PM CDT
Dillard's, Inc. (NYSE: DDS) (the "Company" or "Dillard's"

announced that the Board of Directors declared a cash dividend of $0.07 per share on the Class A and Class B Common Stock of the Company payable August 1, 2016 to shareholders of record as of June 30, 2016.
DDS: 63.88 (-1.19)

Dillard's, Inc. Hosts Annual Meeting of Shareholders
BusinessWire - Sat May 21, 11:19AM CDT
Dillard's, Inc. (NYSE

DS) (the "Company" or "Dillard's"

conducted its annual meeting of shareholders today in Little Rock, Arkansas with Dillard's Chairman of the Board and Chief Executive Officer, William Dillard, II, presiding.
DDS: 63.88 (-1.19)

31.2% Return Seen to Date on SmarTrend Dillard's Call (DDS)
Comtex SmarTrend(R) - Fri May 20, 12:50AM CDT
SmarTrend identified a Downtrend for Dillard's (NYSE

DS) on April 5th, 2016 at $80.58. In approximately 1 month, Dillard's has returned 31.19% as of today's recent price of $55.45.
DDS: 63.88 (-1.19)

Company News for May 16, 2016
Zacks Equity Research - Zacks Investment Research - Mon May 16, 9:10AM CDT
Companies in the News are: NVDA,SHAK,DDS,HMC
DDS: 63.88 (-1.19), SHAK: 38.56 (+0.77), HMC: 26.28 (+0.21), NVDA: 52.78 (-0.02)

Retail Stocks' Earnings to Watch on May 17: HD, TJX, PLCE
Zacks Equity Research - Zacks Investment Research - Mon May 16, 7:03AM CDT
With most sectors signing out of the first-quarter reporting season, the focus has shifted to the Retail space wherein numerous members reported earnings last week and many more are still queued up.
DDS: 63.88 (-1.19), KSS: 38.50 (-1.26), AMZN: 742.63 (-5.58), HD: 133.56 (-1.28), TJX: 78.15 (-0.36), PLCE: 83.01 (-0.55), M: 35.08 (-0.57)

Dillard's (DDS) Stock Down 5% as Q1 Earnings Lag Estimates
Zacks Equity Research - Zacks Investment Research - Fri May 13, 6:40AM CDT
Dillard's Inc. (DDS) reported first-quarter fiscal 2016 earnings of $2.17 per share that missed the Zacks Consensus Estimate of $2.57 and plunged 18.4% on a year-over-year basis.
DDS: 63.88 (-1.19), KR: 37.48 (+0.09), ANF: 19.16 (-0.30), SCVL: 26.86 (+0.08)

Dillard's misses 1Q profit forecasts
Automated Insights - Thu May 12, 3:26PM CDT
LITTLE ROCK, Ark. (AP) _ Dillard's Inc. (DDS) on Thursday reported fiscal first-quarter net income of $77.4 million.
DDS: 63.88 (-1.19)

Dillard's, Inc. Reports First Quarter Results
BusinessWire - Thu May 12, 3:20PM CDT
Dillard's, Inc. (NYSE: DDS) (the "Company" or "Dillard's"

announced operating results for the 13 weeks ended April 30, 2016. This release contains certain forward-looking statements. Please refer to the Company's cautionary statements regarding forward-looking information included below under "Forward-Looking Information."
DDS: 63.88 (-1.19)

Shares of DDS Down 24.2% Since Downtrend Call on Shares
Comtex SmarTrend(R) - Thu May 12, 1:38PM CDT
SmarTrend identified a Downtrend for Dillard's (NYSE

DS) on April 5th, 2016 at $80.58. In approximately 1 month, Dillard's has returned 24.24% as of today's recent price of $61.05.
DDS: 63.88 (-1.19)

Dillard's, Inc. to Report First Quarter Results
BusinessWire - Wed May 11, 3:57PM CDT
Dillard's, Inc. (NYSE: DDS) will announce results for the 13 weeks ended April 30, 2016 after the close of the New York Stock Exchange tomorrow, May 12, 2016.
DDS: 63.88 (-1.19)

Look for Shares of Dillard's to Potentially Rebound after Yesterday's 6.23% Sell Off
Comtex SmarTrend(R) - Wed May 11, 2:58PM CDT
Dillard's (NYSE

DS) traded in a range yesterday that spanned from a low of $63.30 to a high of $65.23. Yesterday, the shares fell 6.2%, which took the trading range below the 3-day low of $65.93 on volume of 547,000 shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
DDS: 63.88 (-1.19)

Dillard's Falls 6.23% on Heavy Volume: Watch For Potential Rebound
Comtex SmarTrend(R) - Wed May 11, 2:57PM CDT
Dillard's (NYSE

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Moore Law Urges Millrose Investors: Join the Action

Is Millrose Playing a Risky Game? When I caught wind of this latest debacle with Millrose Properties, Inc. (NYSE: MRP), my gut reaction was a mix of curiosity and skepticism. Hunterbrook Media's report just blasted across the headlines, digging up some dirt on Millrose's recent financial maneuvers. Apparently, these cats have been busy buying homes to the tune of $200...

TilePix Expands into Walmart with Nail-Free Decor Launch

TilePix Makes Big Moves with Walmart TilePix is launching their new line of nail-free wall décor at Walmart—this ain’t your grandma’s wall art. This company's bringing their magnetic, nail-free wizardry to retail stores nationwide for the first time, and they’ve chosen a real heavyweight partner—Walmart. What comes in the package? Well, they’re dealing in...

AAI Rolls Out Agency Gauge: AI-Driven Insights Platform

Bringing Artificial Intelligence to the Insurance Table Affordable American Insurance (AAI) is shaking things up in the insurance world with their new tool, Agency Gauge. Picture this: you're running an independent agency, neck-deep in data, and this AI-powered marvel swoops in and turns those confusing numbers into actionable business insights. It's like having a wise...

DOCS Faces Investor Legal Battle for Alleged Misconduct

The DOCS Predicament: Investors Facing Class Action Doximity, Inc., trading as NYSE:DOCS, finds itself in hot water again as shareholders gear up for a legal skirmish over alleged securities fraud. Schall, Brown & Schwartz LLP, the firm rallying the shareholders, has fired the opening salvo, pointing fingers at Doximity for cooking the books about their Newsfeed’s...

Roof Inspections: Richmond's Key to Home Longevity

Inspect, Protect, and Forget Your Worries Homeowners in the Greater Richmond area wisely take to heart the old saying: an ounce of prevention is worth a pound of cure. But let's cut through the noise for a moment and zero in on a foundational truth: regular roof inspections are not a luxury—they're an absolute must. Roofing expert Seth Brown, from BNH Roofing, makes it...

AI-Designed Antivirals: A Brave New World

Pushing the Boundaries with AI in Drug Discovery It seems some smart folks over in South Korea are giving the pharma game a fresh twist, pitting artificial intelligence against viral invaders in a newfangled brawl. Professors from Korea University have managed to blend AI's computing prowess with good ol' lab doggedness to sniff out potential antiviral compounds. The...

Kansai Medical Ushers in New Era of Cancer Research

Breaking Ground in Cancer Treatment Trials I've seen some thrilling breakthroughs in my time following the pharmaceutical industry, but what Kansai Medical University and Daiichi Sankyo are doing elevates the game. They're rolling out the first patient dose of DS1025 in Osaka, Japan—a move that marks the onset of a global Phase 1 clinical trial. This is no ordinary...

2GenPen & LordCap Team Up: Game-Changer in ABS?

New Kids on the Structured Credit Block? Well, it looks like we're in for a ride with 2GenPen teaming up with Lord Capital to shake up the asset-backed securities (ABS) world. They're strutting their stuff by launching a strategic collaboration to boost credit analysis. Think of it as a power-up for ABS transactions—because nobody loves a murky credit rating. The Heart...

Ama La Vida's New Coaching: More Than a Financial Plan

Breaking the Retirement Myth Retirement ain't just about sailing off into the sunset with a fat wallet. What happens when the honeymoon period of the "golden years" ends and you're left pacing the floorboards, unsure of what comes next? Enter Ama La Vida's fresh approach to retirement coaching, tackling the side of retirement that's rarely spoken about: identity,...

Endava Faces Securities Fraud Lawsuit: Investor Implications

Endava in Hot Water Over Alleged Misleading Statements Alright, folks, gather around—there's a storm brewing over at Endava with shareholders mightier than the Greek gods, furrowing their brows with intent. You see, Schall, Brown & Schwartz LLP, a firm that practically eats legal challenges for breakfast, is beating the drums of a securities fraud lawsuit. Yep, I'm...